World Vaccines Market 2012-2022


July 25, 2012
199 Pages - SKU: VSG4857883
Attention: There is an updated edition available for this report.
License type:
Table of Contents Related Reports
Countries covered: Global

World Vaccines Market 2012-2022

  enlarge


Why the vaccine market can expand - you discover its commercial potential

Where is the vaccines sector heading? Visiongain's report shows you forecasted revenues to 2022. You see data, trends, opportunities and industry prospects.

Our new study investigates vaccines for human beings, letting you assess projected sales at overall world market, submarket, product and national level. Many segments hold growth potential.

Analysis of submarkets and products

In addition to the overall market, you see revenue forecasting of four world-level submarkets to 2022:
  • Paediatric vaccines
  • Influenza vaccines
  • Adult prophylactic vaccines
  • Therapeutic vaccines.
Also, how will 12 leading products and branded groups - including Prevnar-13, Pentacel, Gardasil and Fluzone - perform to 2022? Our investigation shows business research and analysis with sales forecasts and discussions.

What are the prospects in leading regions and countries?

There are many commercial opportunities in developed and developing countries. You discover revenue forecasts to 2022 for eleven national markets:
  • US
  • Japan
  • Germany, France, UK, Spain and Italy (EU5)
  • Brazil, Russia, India and China (BRIC).
New products from 2012 onwards will benefit world, regional and national markets.

Coverage of research and development

What about the R&D pipeline? You see developmental trends there:
  • Paediatric applications
  • Influenza
  • HPV
  • Adult prophylactic agents
  • HIV
  • Pneumococcal products
  • Therapeutic vaccines.
Technology and other progress will change the sector. The report explains.

What issues affect the vaccines industry and market?

Our study lets you assess industry trends and outlooks worldwide from 2012. You see many discussions:
  • Manufacturing, storage, distribution and supply
  • Emerging applications, including cancers
  • Payers and pricing
  • Safety and regulators
  • Technologies - antigens, adjuvants and delivery systems
  • Policy, pandemics and other issues.
Leading companies and revenue prospects

From 2012 to 2022, biopharma companies will increase the industry's revenues. More vaccination of adults and use of therapeutic vaccines in cancer treatment will stimulate the market.

The R&D pipeline is strong. Also, leading brands retain potential. Our report predicts strong growth in the market's revenues from 2012 to 2022.

Our work discusses Sanofi Pasteur, Pfizer, GSK, Merck and other vaccine developers and manufacturers. This decade, many opportunities will arise for companies.

Commercial news, developmental trends and sales forecasting

In the report you find revenue forecasting, growth rates and market shares. Also, you see qualitative analyses (SWOT and STEP), R&D and commercial developments. You receive 91 tables, 63 charts and a research interview.

Eight ways World Vaccines Market 2012-2022 helps you

In particular, our study gives you the following knowledge on the topic:
  • Find potential revenues to 2022 for the overall world market and submarkets
  • Discover projected revenues of leading products to 2022
  • See market forecasting to 2022 for US, Japan, Germany, France, UK, Spain and Italy (EU5), Brazil, Russia, India and China (BRIC)
  • Assess companies, discovering activities and outlooks
  • Review R&D pipelines, seeing trends
  • View opinions on the sector, including a research interview
  • Investigate competition and opportunities influencing sales
  • Find out what stimulates and restrains the industry and market.
There you find quantitative and qualitative analyses with independent predictions. You receive information unique to our report, helping you stay informed on business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


Additional Information

Companies Listed

Aaron Diamond AIDS Research Center
Abbott Laboratories
Acambis
ACE Biosciences
Activartis Biotech
Adamis Pharmaceuticals
Aduro BioTech
Advaxis
Aerus Global TB Vaccine Foundation
Affiris
Agenus
Akela Pharma
ALK Abello
Allergy Therapeutics
Allertein Therapeutics
AlphaVax
Antigen Express
Antigenics
Aphton
Argos Therapeutics
Astellas Pharma US
AstraZeneca
AuRx
AVAX Technologies
Avant Immunotherapeutics
Baxter Healthcare
Bayer HealthCare
Bayhill Therapeutics
Bellicum Pharmaceuticals
Bharat Biotech
Biken Japan
Biogen Idec
Bill & Melinda Gates Foundation
Biomira
Bionor Pharma
BioSante Pharmaceuticals
Biotech Synergy
Biovest International
BN ImmunoTherapeutics (Bavarian Nordic)
Cancer Advances
CancerVax
Cell Control
Celldex Therapeutics
Cell Genesys
Celltech
CEL-SCI
Celtic Pharma
Centers for Disease Control and Prevention (CDC)
CG Therapeutics
Chemo-Sero-Therapeutic Research Institute
Chiron
Colby Pharmaceutical
Coley Pharmaceuticals
Corixa
Cosmo Pharmaceuticals
Crucell
CSL Behring
Cytokine PharmaSciences
Cytos Biotechnology
DBV Technologies
Dendreon
Denka Seiken
Department of Defense (US)
Dynavax Technologies
DynPort Vaccine
EMD Serono
Emergent BioSolutions
Endocyte
Epeius Biotechnologies
Etubics
European Medicines Agency (EMEA/EMA)
Evans Medica
Favrille
Food and Drug Administration (US FDA)
Galena Biopharma
GeneCure Biotechnologies
Genentech
Genetic Immunity
Genitope
GenPhar
GenVec
GeoVax Labs
Geron
GlaxoSmithKline (GSK)
GlobeImmune
Gradalis
Greer Laboratories
Hawaii Biotech
Heat Biologics
iBio
Ichor Medical Systems
immatics biotechnologies
Immunitor
ImmunoCellular Therapeutics
Immunocore
Immunofrontier
Immunotope
Immunovaccine
Infectious Diseases Research Institute
Inovio Pharmaceuticals
Institut Pasteur
Intercell
Intercell USA
International Vaccine Institute
Intracel
Inviragen
Janssen Alzheimer Immunotherapy
JN-International Medical
Johns Hopkins University
KAEL-GemVax
Kitasato Institute
LigoCyte Pharmaceuticals
Liquidia Technologies
Ludwig Institute for Cancer Research
MabVax Therapeutics
MaxCyte
Medeva
Medicago USA
MedImmune
Medirace
Memgen
Menarini
Merck & Co.
Merck KGaA
Meridian Biosciences
Momotaro-Gene
Nabi Biopharmaceuticals
NanoBio
Nanotherapeutics
National Institutes of Health (NIH, US)
Neurological Disorders
NewLink Genetics
Northwest Biotherapeutics
Novadigm Therapeutics
Novartis
NovaRx
Novavax
Novo Energies
NuVax Therapeutics
Okairos
Oncothyreon
OncoVax
Opal Therapeutics
Optimer Pharmaceuticals
Orban Biotech
Oxford BioMedica
PaxVax
Pfizer
PharmAthene
Pique Therapeutics
Polynoma
Powderject
Prima Biomed
Profectus Biosciences
Progenics Pharmaceuticals
Protein Sciences
Quantum Immunologics
Quest PharmaTech
Roche
Sabin Vaccine Institute
Sanaria
Sanofi
Sanofi Pasteur
Selecta Biosciences
Sinovac
Soligenix
Stallergenes
Stemline Therapeutics
Takeda
Teva Pharmaceutical Industries
The GAVI Alliance
Theraclone Sciences
Thymon
Transgene
TVAX Biomedical
UNICEF
United Biomedical
University of Queensland
University Hospital of Tubingen
US Naval Medical Research Center
Vaccine Research Center (NIAID)
Vaccine Technologies
Vaccinogen
Vaxart
VaxGen
Vaxin
VaxInnate
VaxOnco
Vical
WHO (World Health Organization)
Xcellerex

More Pandemic Vaccines reports by Visiongain

Pharma Leader Series: Top Pre-Filled Injection Device Manufacturers 2012-2022 by Visiongain
Pre-filled syringes - discover potentials and prospects of companies there How are companies in the pre-filled syringe industry performing? Visiongain's report gives you ...
Needle-Free Delivery: Technology and Market 2012-2022 by Visiongain
The technology and devices for needle-free delivery of drugs/vaccines has been available in the market since several decades. Although their market penetration has been low, ...
World Influenza Vaccines Market 2011-2021 by Visiongain
Are you looking for influenza vaccine market data - answers to benefit your work? Our new report shows you revenue prospects for the manufacture and ...
See all reports like this >>

More Global Pandemic Vaccines reports

Global Vaccine Market Forecast to 2017 by RNCOS
Of late, the vaccines market is burgeoning with immense activities. Big pharmaceutical companies like GSK, Pfizer, Merck etc. are struggling to maintain their revenue and ...
The 2013-2018 World Outlook for Influenza Vaccines by Icon Group International, Inc.
The 2013-2018 World Outlook for Influenza Vaccines-This econometric study covers the world outlook for influenza vaccines across more than 200 countries. For each year reported, ...
Global H1N1 Vaccines Market 2011-2015 by Infiniti Research Limited
TechNavio's analysts forecast the Global H1N1 Vaccines market to decline at a CAGR of -33 percent over the period 2011-2015. One of the key factors ...
Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments by Kalorama Information
This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Pandemic Vaccines Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!